Thurly, this Ph.2/3 doesn’t eval. for safety line is just the latest in a series of difficult to comprehend statements/positions from our friend Moby, like: Proxy saying 15mm Incentive-Plan shares will be split adjusted means they won’t be, Garnick is here only to start trials with 2nd gen. mabs not Bavi, 80% of Peregrine/Avid’s 135 emps are part-timers, let’s look at Jan-July’09 OS (not Apr-July) to gage the “the spike during 2009 ASCO”, and now: they test for safety in Phase I, not II or III.
I tried and tried to get to the bottom of those statements - to no avail.
I appreciate all your many contributions here, BTW.
Market Data 
Markets 
AI
